PCR & Real-time PCR Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

PCR & Real-time PCR Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

  • Transparency Market Research
  • September 2020
  • Medical Equipments
  • 180 pages

Report Description

1
1

PCR & Real-time PCR Molecular Diagnostics Market – Scope of the Report

TMR’s report on the global PCR & real-time PCR molecular diagnostics market studies the past as well as current growth trends and opportunities to gain valuable insights for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global PCR & real-time PCR molecular diagnostics market for period from 2018 to 2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global PCR & real-time PCR molecular diagnostics market for the same period.

The report has been prepared after extensive research. Primary research involves bulk of research efforts, wherein analysts conducted interviews with market leaders and opinion makers. Secondary research involves referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global PCR & real-time PCR molecular diagnostics market.

Secondary research also includes Internet sources and statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of top-down and bottom-up approaches to study various phenomena in the global PCR & real-time PCR molecular diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth pattern of various market segments included in the scope of the study. Furthermore, the report sheds light on the changing competition dynamics in the global PCR & real-time PCR molecular diagnostics market. These indices serve as valuable tools for existing market players as well as new players interested in entering the global PCR & real-time PCR molecular diagnostics market. The next section of the report highlights the USPs, which include regulatory scenario, overview of in-vitro diagnostics market, technological advancement, key industry events (mergers, acquisitions, collaborations, approvals, etc.), and COVID-19 pandemic impact on industry (value chain and short/mid/long-term impact).

The report delves into the competitive landscape of the global PCR & real-time PCR molecular diagnostics market. Key players operating in the global PCR & real-time PCR molecular diagnostics market have been identified and each one of them has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players operating in the global PCR & real-time PCR molecular diagnostics market profiled in this report.

Key Questions Answered in PCR & Real-time PCR Molecular Diagnostics Market Report

  • What are major drivers, restraints, and opportunities in the global PCR & real-time PCR molecular diagnostics market?
  • What is the revenue share projection of key segments of the global PCR & real-time PCR molecular diagnostics market during the forecast period?
  • Which segment is likely to lead the global PCR & real-time PCR molecular diagnostics market in terms of revenue between 2020 and 2030?
  • How mergers & acquisitions among players are widening the scope of the global PCR & real-time PCR molecular diagnostics market?
  • What is the market position of different companies operating in the global PCR & real-time PCR molecular diagnostics market?

PCR & Real-time PCR Molecular Diagnostics Market – Research Objectives and Research Approach

The comprehensive report on the global PCR & real-time PCR molecular diagnostics market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of objectives of this study and healthcare compliances laid down by accredited agencies in the purview of research in the global PCR & real-time PCR molecular diagnostics market. It is followed by market introduction, market dynamics, and an overview of the global PCR & real-time PCR molecular diagnostics market, which includes TMR’s analysis of market drivers, restraints, and trends pertaining to the global PCR & real-time PCR molecular diagnostics market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global PCR & real-time PCR molecular diagnostics market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout with each section further divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

The report segments the global PCR & real-time PCR molecular diagnostics market in terms of technology, product, application, end user, and region. Key segments under each criterion have been studied at length and the market share for each segment by the end of 2030 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investments in the global PCR & real-time PCR molecular diagnostics market.

PCR and Real-time PCR Molecular Diagnostics Market – Segmentation

Technology

  • Traditional PCR
  • Real-time PCR
  • Digital PCR

Product

  • Instruments
  • Reagents
  • Consumables

Application

  • Infectious Diseases Testing
  • HCV & HBV
  • Sexually Transmitted Infections
  • Hospital Acquired Infection
  • Respiratory Infections
  • Others
  • Oncology Testing
  • Genetic Testing
  • Others

End User

  • Hospitals
  • Diagnostic Laboratories
  • Academic & Academic & Research Centers
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Have query on this report?

Make an Enquiry

Table of Content

 

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global PCR & Real-time PCR Molecular Diagnostics Market

4. Market Overview

4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast, 2018–2030

5. Market Outlook
5.1. Technology Advancement
5.2. Key Industry Events (Mergers, Acquisitions, Collaborations, Partnerships, etc.)
5.3. COVID-19 Pandemic Impact on Industry (Value Chain and Short /Mid / Long-term Impact) Pricing Analysis

6. Global PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology
6.1. Introduction & Definition
6.2. Global PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030
6.2.1. Traditional PCR
6.2.2. Real-time PCR
6.2.3. Digital PCR
6.3. Global PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Technology

7. Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product
7.1. Introduction & Definition
7.2. Global PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030
7.2.1. Instruments
7.2.2. Reagents
7.2.3. Consumables
7.3. Global PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Product

8. Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn)  Forecast, by Application
8.1. Introduction & Definition
8.2. Global PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030
8.2.1. Infectious Diseases Testing
8.2.1.1. HCV & HBV
8.2.1.2. Sexually Transmitted Infections
8.2.1.3. Hospital Acquired Infection
8.2.1.4. Respiratory Infections
8.2.1.5. Others
8.2.2. Oncology Testing
8.2.3. Genetic Testing
8.2.4. Others
8.3. Global PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Application

9. Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user
9.1. Introduction & Definition
9.2. Global PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2018–2030
9.2.1. Hospitals
9.2.2. Diagnostic Laboratories
9.2.3. Academic & Research Centers
9.2.4. Others
9.3. Global PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by End-user

10. Global PCR & Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast, by Region
10.1. Introduction
10.2. Global PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Region, 2018–2030
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Global PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis, by Region

11. North America PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast
11.1. Introduction
11.2. North America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030
11.2.1. Traditional PCR
11.2.2. Real-time PCR
11.2.3. Digital PCR
11.3. North America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Product, 2018–2030
11.3.1. Instruments
11.3.2. Reagents
11.3.3. Consumables
11.4. North America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Application, 2018–2030
11.4.1. Infectious Diseases Testing
11.4.1.1. HCV & HBV
11.4.1.2. Sexually Transmitted Infections
11.4.1.3. Hospital Acquired Infection
11.4.1.4. Respiratory Infections
11.4.1.5. Others
11.4.2. Oncology Testing
11.4.3. Genetic Testing
11.4.4. Others
11.5. North America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2018–2030
11.5.1. Hospitals
11.5.2. Diagnostic Laboratories
11.5.3. Academic & Research Centers
11.6. North America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Country, 2018–2030
11.6.1. U.S.
11.6.2. Canada
11.7. North America PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis
11.7.1. By Technology
11.7.2. By Product
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country

12. Europe PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast
12.1. Introduction
12.2. Europe PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030
12.2.1. Traditional PCR
12.2.2. Real-time PCR
12.2.3. Digital PCR
12.3. Europe PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Product, 2018–2030
12.3.1. Instruments
12.3.2. Reagents
12.3.3. Consumables
12.4. Europe PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Application, 2018–2030
12.4.1. Infectious Diseases Testing
12.4.1.1. HCV & HBV
12.4.1.2. Sexually Transmitted Infections
12.4.1.3. Hospital Acquired Infection
12.4.1.4. Respiratory Infections
12.4.1.5. Others
12.4.2. Oncology Testing
12.4.3. Genetic Testing
12.4.4. Others
12.5. Europe PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2018–2030
12.5.1. Hospitals
12.5.2. Diagnostic Laboratories
12.5.3. Academic & Research Centers
12.6. Europe PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Country/Sub-region, 2018–2030
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Europe PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis
12.7.1. By Technology
12.7.2. By Product
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region

13. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast
13.1. Introduction
13.2. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030
13.2.1. Traditional PCR
13.2.2. Real-time PCR
13.2.3. Digital PCR
13.3. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Product, 2018–2030
13.3.1. Instruments
13.3.2. Reagents
13.3.3. Consumables
13.4. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Application, 2018–2030
13.4.1. Infectious Diseases Testing
13.4.1.1. HCV & HBV
13.4.1.2. Sexually Transmitted Infections
13.4.1.3. Hospital Acquired Infection
13.4.1.4. Respiratory Infections
13.4.1.5. Others
13.4.2. Oncology Testing
13.4.3. Genetic Testing
13.4.4. Others
13.5. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2018–2030
13.5.1. Hospitals
13.5.2. Diagnostic Laboratories
13.5.3. Academic & Research Centers
13.6. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Country/Sub-region, 2018–2030
13.6.1. Japan
13.6.2. China
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis
13.7.1. By Technology
13.7.2. By Product
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region

14. Latin America PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast
14.1. Introduction
14.2. Latin America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030
14.2.1. Traditional PCR
14.2.2. Real-time PCR
14.2.3. Digital PCR
14.3. Latin America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Product, 2018–2030
14.3.1. Instruments
14.3.2. Reagents
14.3.3. Consumables
14.4. Latin America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Application, 2018–2030
14.4.1. Infectious Diseases Testing
14.4.1.1. HCV & HBV
14.4.1.2. Sexually Transmitted Infections
14.4.1.3. Hospital Acquired Infection
14.4.1.4. Respiratory Infections
14.4.1.5. Others
14.4.2. Oncology Testing
14.4.3. Genetic Testing
14.4.4. Others
14.5. Latin America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2018–2030
14.5.1. Hospitals
14.5.2. Diagnostic Laboratories
14.5.3. Academic & Research Centers
14.6. Latin America PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Country/Sub-region, 2018–2030
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Latin America PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis
14.7.1. By Technology
14.7.2. By Product
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region

15. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Analysis and Forecast
15.1. Introduction
15.2. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Technology, 2018–2030
15.2.1. Traditional PCR
15.2.2. Real-time PCR
15.2.3. Digital PCR
15.3. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Product, 2018–2030
15.3.1. Instruments
15.3.2. Reagents
15.3.3. Consumables
15.4. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Application, 2018–2030
15.4.1. Infectious Diseases Testing
15.4.1.1. HCV & HBV
15.4.1.2. Sexually Transmitted Infections
15.4.1.3. Hospital Acquired Infection
15.4.1.4. Respiratory Infections
15.4.1.5. Others
15.4.2. Oncology Testing
15.4.3. Genetic Testing
15.4.4. Others
15.5. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by End-user, 2018–2030
15.5.1. Hospitals
15.5.2. Diagnostic Laboratories
15.5.3. Academic & Research Centers
15.6. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Value Forecast, by Country/Sub-region, 2018–2030
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market Attractiveness Analysis
15.7.1. By Technology
15.7.2. By Product
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region

16. Competition Landscape
16.1. Market Player - Competition Matrix (by tier and size of companies)
16.2. Global PCR & Real-time PCR Molecular Diagnostics Market Position Analysis, by Company, 2019
16.3.  Company Profiles
16.3.1. Abbott Laboratories
16.3.1.1. Company Description
16.3.1.2. Business Overview
16.3.1.3. Financial Overview
16.3.1.4. Strategic Overview
16.3.1.5. SWOT Analysis
16.3.2. Elekta AB Bio-Rad Laboratories, Inc.
16.3.2.1. Company Description
16.3.2.2. Business Overview
16.3.2.3. Financial Overview
16.3.2.4. Strategic Overview
16.3.2.5. SWOT Analysis
16.3.3. bioMérieux SA
16.3.3.1. Company Description
16.3.3.2. Business Overview
16.3.3.3. Financial Overview
16.3.3.4. Strategic Overview
16.3.3.5. SWOT Analysis
16.3.4. Danaher Corporation
16.3.4.1. Company Description
16.3.4.2. Business Overview
16.3.4.3. Strategic Overview
16.3.4.4. Financial Overview
16.3.4.5. SWOT Analysis
16.3.5. Thermo Fisher Scientific, Inc.
16.3.5.1. Company Description
16.3.5.2. Business Overview
16.3.5.3. Strategic Overview
16.3.5.4. Financial Overview
16.3.5.5. SWOT Analysis
16.3.6. Becton, Dickinson and Company
16.3.6.1. Company Description
16.3.6.2. Business Overview
16.3.6.3. Strategic Overview
16.3.6.4. Financial Overview
16.3.6.5. SWOT Analysis
16.3.7. F. Hoffmann-La Roche Ltd
16.3.7.1. Company Description
16.3.7.2. Business Overview
16.3.7.3. Strategic Overview
16.3.7.4. Financial Overview
16.3.7.5. SWOT Analysis
16.3.8. QIAGEN N.V.
16.3.8.1. Company Description
16.3.8.2. Business Overview
16.3.8.3. Strategic Overview
16.3.8.4. Financial Overview
16.3.8.5. SWOT Analysis
16.3.9. Hologic, Inc.
16.3.9.1. Company Description
16.3.9.2. Business Overview
16.3.9.3. Strategic Overview
16.3.9.4. Financial Overview
16.3.9.5. SWOT Analysis
16.3.10. GRIFOLS, S.A.
16.3.10.1. Company Description
16.3.10.2. Business Overview
16.3.10.3. Strategic Overview
16.3.10.4. Financial Overview
16.3.10.5. SWOT Analysis
16.3.11. Genomic Health
16.3.11.1. Company Description
16.3.11.2. Business Overview
16.3.11.3. Strategic Overview
16.3.11.4. Financial Overview
16.3.11.5. SWOT Analysis
16.3.12. Seegene, Inc.
16.3.12.1. Company Description
16.3.12.2. Business Overview
16.3.12.3. Strategic Overview
16.3.12.4. Financial Overview
16.3.12.5. SWOT Analysis

 

List of Tables

Table 01 Global In-vitro Diganostics (IVD) Market for Infectious Disease, Oncology, Genetics Market Value Analysis and Forecast, 2018–2030
Table 02 Global PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Technology, 2018–2030
Table 03 Global PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Product, 2018–2030
Table 04 Global PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Application, 2018–2030
Table 05 Global PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Infectious Diseases, 2018–2030
Table 06 Global PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 07 Global PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Region, 2018–2030
Table 08 North America PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Country, 2018–2030
Table 09 North America PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Technology, 2018–2030
Table 10 North America PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Product, 2018–2030
Table 11 North America PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Application, 2018–2030
Table 12 North America PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Infectious Diseases, 2018–2030
Table 13 North America PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 14 Europe PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 15 Europe PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Technology, 2018–2030
Table 16 Europe PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Product, 2018–2030
Table 17 Europe PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Application, 2018–2030
Table 18 Europe PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Infectious Diseases, 2018–2030
Table 19 Europe PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 20 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 21 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Technology, 2018–2030
Table 22 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Product, 2018–2030
Table 23 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Application, 2018–2030
Table 24 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Infectious Diseases, 2018–2030
Table 25 Asia Pacific PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 26 Latin America PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 27 Latin America PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Technology, 2018–2030
Table 28 Latin America PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Product, 2018–2030
Table 29 Latin America PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Application, 2018–2030
Table 30 Latin America PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Infectious Diseases, 2018–2030
Table 31 Latin America PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 32 Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 33 Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Technology, 2018–2030
Table 34 Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Product, 2018–2030
Table 35 Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Application, 2018–2030
Table 36 Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by Infectious Diseases, 2018–2030
Table 37 Middle East & Africa PCR & Real-time PCR Molecular Diagnostics Market  Value (US$ Mn) Forecast, by End-user, 2018–2030

Success Stories

Our Clients

Tell Us What You Need and We’ll Get Back with the Best Solutions Available.

*
*
*

get in touch

Location :

State Tower, 90 State Street, Suite 700, Albany NY - 12207, United States

Call Us :

US/Canada toll free : 866-997-4948

Tel : +1-518-621-2074